Trial Profile
A study to evaluate the safety and efficacy of rilonacept in patients with deficiency of interleukin-1 receptor antagonist.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Rilonacept (Primary)
- Indications Deficiency of interleukin-1 receptor antagonist
- Focus Therapeutic Use
- 28 Aug 2015 New trial record